Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.
As of close of business last night, Xenon Pharmaceuticals Inc’s stock clocked out at $37.59, up 2.34% from its previous closing price of $36.73. In other words, the price has increased by $2.34 from its previous closing price. On the day, 0.7 million shares were traded.
Ratios:
To gain a deeper understanding of XENE’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 17.85 and its Current Ratio is at 17.85. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.01.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Deutsche Bank on February 11, 2025, initiated with a Buy rating and assigned the stock a target price of $67.
On October 01, 2024, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $53.H.C. Wainwright initiated its Buy rating on October 01, 2024, with a $53 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Jan 24 ’25 when MORTIMER IAN sold 22,468 shares for $40.20 per share. The transaction valued at 903,214 led to the insider holds 31,302 shares of the business.
MORTIMER IAN sold 16,315 shares of XENE for $660,806 on Jan 27 ’25. The PRESIDENT & CEO now owns 31,302 shares after completing the transaction at $40.50 per share. On Jan 23 ’25, another insider, MORTIMER IAN, who serves as the PRESIDENT & CEO of the company, sold 16,217 shares for $40.08 each. As a result, the insider received 649,977 and left with 31,302 shares of the company.
Stock Price History:
Over the past 52 weeks, XENE has reached a high of $46.00, while it has fallen to a 52-week low of $26.74. The 50-Day Moving Average of the stock is 6.52%, while the 200-Day Moving Average is calculated to be -4.55%.
Shares Statistics:
A total of 76.42M shares are outstanding, with a floating share count of 74.20M. Insiders hold about 3.05% of the company’s shares, while institutions hold 97.31% stake in the company.
